# Nextech Invest: portfolio, investments and team

> Nextech Invest is a private equity based in Switzerland. 15 investments on record, 2 in the last 12 months, latest Oct 2026.

Source: https://millionrounds.com/fund/nextech-invest (Millionrounds; every figure on the page links to its filing or article)

Switzerland · [Investor](https://millionrounds.com/investors)

# Nextech Invest

Last cheque observed Oct 2026; 15 cheques on record.

Email

Deploying now Private equity

Seed Series A Series B Biomarker Bioimaging In Vitro Diagnostics

Follow Nextech Invest and see its new cheques in your feed. [Start following](https://millionrounds.com/login?join=1&why=follow&next=%2Ffund%2Fnextech-invest)

Deploying now

**100%** of best year **2** **cheques in 12 months**, 15 on record

Since the last cheque **25** days **00** hrs **00** min **00** sec

Median round **$68M** Rounds led **3 of 15** Mostly in **United States, 100%**

Pitch Nextech Invest

## Nextech Invest highlights

- 01 2 cheques in the last 12 months
- 02 Mostly Series B and Series C: 92% of its rounds
- 03 Led 3 rounds

## What they do

> we fuel the success of emerging biotechnology companies worldwide by identifying transformative cancer medicines. From their own website

- **Type:** Private equity (from a list, unverified)
- **Cheque size:** Not stated
- **Stages:** Seed Series A Series B Growth
- **Sectors:** Biomarker Bioimaging In Vitro Diagnostics
- **Based in:** Zurich, Switzerland
- **Cold pitches:** Not accepted

## The record

Every round we can evidence, newest first **15 appearances**

- **2026** 2 rounds
- **Oct** **[Matchpoint Therapeutics](https://millionrounds.com/company/matchpoint-therapeutics)** Series B · US · Firms' own news pages **$150M** *Led*
- **Aug** **[Khartis Therapeutics](https://millionrounds.com/company/khartis-therapeutics)** Series B · US · Ventureburn **$50M** With 5 others
- **2019** 5 rounds
- **Dec** **[Kinnate Biopharma](https://millionrounds.com/company/kinnate-biopharma)** Series B · US · FinSMEs **$75M** With 4 others
- **Nov** **[PMV Pharma](https://millionrounds.com/company/pmv-pharma)** Series C · US · Prweb **$62M** *Led*
- **Nov** **[A2 Biotherapeutics](https://millionrounds.com/company/a2-biotherapeutics)** Series A · US · FinSMEs **$57M** With 3 others
- **Jul** **[Revolution Medicines](https://millionrounds.com/company/revolution-medicines)** Series C · US · FinSMEs **$100M** With 9 others
- **Apr** **[Arrakis Therapeutics](https://millionrounds.com/company/arrakis-therapeutics)** Series B · US · FinSMEs **$75M** *Led*
- **2018** 1 round
- **Oct** **[TP Therapeutics](https://millionrounds.com/company/tp-therapeutics)** US · FinSMEs **$80M** With 6 others
- **2017** 1 round
- **Dec** **[Neon Therapeutics](https://millionrounds.com/company/neon-therapeutics)** Series B · US · FinSMEs **$36M** With 8 others
- **2016** 1 round
- **Aug** **[Cleave Bioscience](https://millionrounds.com/company/cleave-bioscience)** Series B · US · FinSMEs **$37M** With 2 others
- **2015** 2 rounds
- **Apr** **[Jounce Therapeutics](https://millionrounds.com/company/jounce-therapeutics)** Series B · US **$56M** With 7 others
- **Mar** **[Kura Oncology](https://millionrounds.com/company/kura-oncology)** US **$60M** With 3 others
- **2014** 3 rounds
- **Sept** **[TRACON Pharmaceuticals](https://millionrounds.com/company/tracon-pharmaceuticals)** Series B · US **$27M** With 5 others
- **May** **[ImaginAb](https://millionrounds.com/company/imaginab)** Series B · US **$21M** With 3 others
- **Jan** **[Blueprint Medicines](https://millionrounds.com/company/blueprint-medicines)** Series B · US **$25M** With 5 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

## The team

Named by the firm itself, on a filing, its Form ADV or its company registration **5 named**

AS **Alfred Scheidegger** Managing Partner i Form ADV

JH **Jakob Henrik Loven** Managing Partner i Form ADV

MC **Marco Christian Weibel** Chief Compliance Officer and Chief Financial Officer i Form ADV

RJ **Rocco Joseph Sgobbo** Managing Partner and Chief Operating Officer i Form ADV

TS **Thilo Schroeder** Managing Partner i Form ADV

We also hold **19** people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

## What the register says

From the firm's own filings with the SEC, which it must file accurately by law

**$2.0B** gross assets of its funds Oct 2026

**Exempt** reporting adviser venture or small private funds

- **Legal name:** Nextech Invest LTD.
- **SEC number:** CRD 322629

## What they claim to have backed

From their own portfolio page (on their website)

**40** of 45 we have independently watched raise

[ARS Pharmaceuticals](https://millionrounds.com/company/ars-pharmaceuticals)[AiRNA](https://millionrounds.com/company/airna)[Alpha-9 Oncology](https://millionrounds.com/company/alpha-9-oncology)[Alterome Therapeutics](https://millionrounds.com/company/alterome-therapeutics)[Alumis](https://millionrounds.com/company/alumis)[Arvinas](https://millionrounds.com/company/arvinas)[Atavistik Bio](https://millionrounds.com/company/atavistik-bio)[Attovia Therapeutics](https://millionrounds.com/company/attovia-therapeutics)[Be Biopharma](https://millionrounds.com/company/be-biopharma)[Black Diamond Therapeutics, Inc](https://millionrounds.com/company/black-diamond-therapeutics)[Blueprint Medicines](https://millionrounds.com/company/blueprint-medicines)[Boundless Bio](https://millionrounds.com/company/boundless-bio)[C4 Therapeutics](https://millionrounds.com/company/c4-therapeutics)[Circle Pharma](https://millionrounds.com/company/circle-pharma)[Cleave Biosciences](https://millionrounds.com/company/cleave-therapeutics)[Context Therapeutics](https://millionrounds.com/company/context-therapeutics)[Cullinan Therapeutics](https://millionrounds.com/company/cullinan-therapeutics)[EQRx](https://millionrounds.com/company/revolution-medicines)[Exo Therapeutics](https://millionrounds.com/company/exo-therapeutics)[Hexagon Bio](https://millionrounds.com/company/hexagon-bio)[IconOVir Bio](https://millionrounds.com/company/iconovir-bio)[Ideaya Biosciences](https://millionrounds.com/company/ideaya-biosciences)[Khartis Therapeutics](https://millionrounds.com/company/khartis-therapeutics)[Kinnate Biopharma](https://millionrounds.com/company/kinnate-biopharma)[Kronos Bio](https://millionrounds.com/company/kronos-bio)[Kuraoncology](https://millionrounds.com/company/kura-oncology)[Mariana Oncology](https://millionrounds.com/company/mariana-oncology)[Mersana Therapeutics](https://millionrounds.com/company/mersana-therapeutics)[Neon Therapeutics](https://millionrounds.com/company/neon-therapeutics)[ORIC Pharmaceuticals](https://millionrounds.com/company/oric-pharmaceuticals)[PMV Pharma](https://millionrounds.com/company/pmv-pharmaceuticals)[Parabilis Medicines](https://millionrounds.com/company/parabilis-medicines)[Peloton Therapeutics](https://millionrounds.com/company/peloton-therapeutics)[ProfoundBio](https://millionrounds.com/company/profoundbio)[Silence Therapeutics](https://millionrounds.com/company/silence-therapeutics)[TYRA Biosciences](https://millionrounds.com/company/tyra-biosciences)[Tubulis](https://millionrounds.com/company/tubulis)[Turning Point Therapeutics,](https://millionrounds.com/company/tp-therapeutics)[Vividion Therapeutics](https://millionrounds.com/company/vividion-therapeutics)[Zymeworks](https://millionrounds.com/company/zymeworks) A2 Biotherapeutics Autolus Therapeutics plc ITM Laronde Bio Sail Biomedicines

Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.

## The cheque

Seed Series A Series B

Median round joined **$68M** the round, not its cheque

Led 3 of 15 rounds **20%**

- **Sole investor:** Never alone
- **Last cheque:** Oct 2026

Rounds by stage said on their site

- Series B said *10*
- Series C *2*
- Series A said *1*
- Seed said *-*
- Growth said *-*

Cheques by month Led Joined

Dec 2023 Nov 2026

Often in the room with

- [Casdin Capital](https://millionrounds.com/fund/casdin-capital) 4
- [Foresite Capital](https://millionrounds.com/fund/forsite-capital) 4
- [Fidelity](https://millionrounds.com/fund/fidelity) 3
- [OrbiMed](https://millionrounds.com/fund/orbimed) 3
- [Access Industries](https://millionrounds.com/fund/access-industries) 2
- [Arcus Ventures](https://millionrounds.com/fund/arcus-ventures) 2

**Pitching Nextech Invest?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque.

Add to your CRM *→*

## Who they invest alongside

The investors most often in the same rounds as Nextech Invest. A count of rooms they were both in, not a relationship either has claimed.

[**Casdin Capital** VC firm **4** rounds together](https://millionrounds.com/fund/casdin-capital)[**Foresite Capital** Private equity **4** rounds together](https://millionrounds.com/fund/forsite-capital)[**Fidelity** VC firm **3** rounds together](https://millionrounds.com/fund/fidelity)[**OrbiMed** Private equity **3** rounds together](https://millionrounds.com/fund/orbimed)[**Access Industries** Corporate VC **2** rounds together](https://millionrounds.com/fund/access-industries)[**Arcus Ventures** VC firm **2** rounds together](https://millionrounds.com/fund/arcus-ventures)[**Boxer Capital** VC firm **2** rounds together](https://millionrounds.com/fund/boxer-capital)[**Celgene** Growth equity **2** rounds together](https://millionrounds.com/fund/celgene)[**Cormorant Capital** VC firm **2** rounds together](https://millionrounds.com/fund/cormorant-capital)[**Lilly Asia Ventures** VC firm **2** rounds together](https://millionrounds.com/fund/lilly-asia-ventures)[**Omega Funds** VC firm **2** rounds together](https://millionrounds.com/fund/omega-funds)[**Osage University Partners** VC firm **2** rounds together](https://millionrounds.com/fund/osage-university-partners)

## Recently backed

The latest companies Nextech Invest put money into.

[**Matchpoint Therapeutics** $150M · Oct 2026](https://millionrounds.com/company/matchpoint-therapeutics)[**A2 Biotherapeutics** $57M · Nov 2019](https://millionrounds.com/company/a2-biotherapeutics)[**Revolution Medicines** $100M · Jul 2019](https://millionrounds.com/company/revolution-medicines)[**Arrakis Therapeutics** $75M · Apr 2019](https://millionrounds.com/company/arrakis-therapeutics)

## Quick answers about Nextech Invest

### What does Nextech Invest invest in?

Nextech Invest invests most often at Series B and Series C (92% of the rounds on record), in sectors such as Biomarker, Bioimaging and In Vitro Diagnostics.

### How active is Nextech Invest?

15 investments on record, 2 of them in the last 12 months, and it led 3. The most recent was in Oct 2026.

### What has Nextech Invest invested in recently?

Its most recent investments on record: Matchpoint Therapeutics (Series B, Oct 2026), Khartis Therapeutics (Series B, Aug 2026) and Kinnate Biopharma (Series B, Dec 2019).

### How big are Nextech Invest's cheques?

The median round it joins is $68M.

### Does Nextech Invest lead rounds?

Yes: it led 3 of its 15 investments on record (20%).

### Where does Nextech Invest invest?

Most of the companies it backs are in the United States (100%).

### Is Nextech Invest investing now?

Yes: it is actively investing, with 2 investments in the last 12 months.

### Who does Nextech Invest invest alongside?

Most often Casdin Capital (4 rounds together), Foresite Capital (4 rounds together) and Fidelity (3 rounds together).

## Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=nextech-invest) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=nextech-invest)